Work

Vaccination should not be forgotten in patients receiving immunoglobulin replacement therapy

Year: 2025

Type: article

Source: Blood Advances

DOI: 10.1182/bloodadvances.2025018127

Authors: Sigrun Einarsdottir, Silvia Escribano-Serrat, Marina Gomez-Llobell, Malin Hultcrantz, Mini Kamboj, Miguel-Angel Perales, Roni Shouval, Zainab Shahid, Per Ljungman

Institutions: Memorial Sloan Kettering Cancer Center, Sahlgrenska University Hospital, Universitat Autònoma de Barcelona, Weill Cornell Medicine, Karolinska University Hospital, Karolinska Institutet

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,800

Funders: Bristol-Myers Squibb, GlaxoSmithKline, Sanofi, Gilead Sciences, Celgene, Cidara Therapeutics, BeiGene, Incyte, Omeros Corporation, Moderna, Springworks Therapeutics, Daiichi Sankyo Europe

Award: G5316515788

OpenAlex ID: W4414320845

FWCI: 1.114

Cites: 25

Cited by: 3

Related to: 10